...

Case Challenge

Management of a Patient Who Develops Psychiatric Adverse Events While Receiving Peginterferon Therapy for HCV

Source: Management of Depression and HCV: Novel Data, Best Practices, and Case Challenges

Management of a Patient Who Develops Psychiatric Adverse Events While Receiving Peginterferon Therapy for HCV


Faculty:

Mark S. Sulkowski, MD
  • Mark S. Sulkowski, MD

CREDIT INFORMATION

Release Date: 09/08/08

Expiration Date: 09/07/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Begin the Case Challenge

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss when prophylactic antidepressants should be used in patients requiring HCV therapy
  • Articulate how the symptoms of depression differ from those of mania
  • Recall strategies to discontinue mood therapy when HCV therapy is no longer indicated

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.